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The most common form of muscular
dystrophy is Duchenne muscular dystro-
phy (DMD), which is an X-linked disor-
der affecting 1 in 3500 newborn males
across the world. DMD is caused by the
lack of dystrophin which is a protein
that provides stability to the sarcolemma
and is likely involved in the transmission
of force between the extracellular matrix
and the intracellcular contractile appa-
ratus (Lovering and Brooks, 2013). Due
to the absence of this protein, the sar-
colemma is easily damaged in response
to muscle contraction (Markert et al.,
2012). Although there is no cure for DMD,
exercise has been proposed as a possi-
ble treatment; however, the risk of muscle
damage is a large concern for this popula-
tion (Markert et al., 2012). Therefore, tra-
ditional strength training which includes
high load eccentric contractions may need
to be avoided in patients with DMD due
to the susceptibility of muscle damage
with lengthening contractions. In addi-
tion, although submaximal exercise may
exert some benefits for this population, the
low load exercise is unlikely to be an opti-
mal stimulus for maintaining or increas-
ing muscle function. Interestingly, there
are numerous studies (>40) in healthy
subjects which suggest that submaximal
exercise in combination with blood flow
restriction (BFR) can elicit muscle adapta-
tions similar to that observed with higher
load resistance training (Loenneke et al.,
2012c) without increasing indices of mus-
cle damage (Loenneke et al., 2011).
Briefly, BFR is a stimulus commonly
applied with specialized pressure cuffs
placed at the top of a limb which are
inflated to a set pressure throughout
exercise. The pressure applied should be
high enough to occlude venous return
from the muscle but low enough to
maintain arterial inflow into the muscle.
Available evidence indicates that the pres-
sure applied should be based on the size
of the limb (i.e., bigger the limb higher
the pressure) (Loenneke et al., 2012b). The
proposed mechanisms (Loenneke et al.,
2012a) behind the effects of low load
exercise in combination with BFR on
skeletal muscle include acute muscle cell
swelling, increased fiber type recruitment
from metabolic accumulation, decreased
myostatin (48 h after last training ses-
sion), decreased atrogenes (8 h post exer-
cise), and the proliferation of satellite cells
(8 days into training intervention, 3 and 10
days after cessation of training) (Nielsen
et al., 2012).
A recent review discussed 5 mech-
anisms of DMD pathology which may
improve or worsen as a result of exer-
cise training which included: (1) mechan-
ical weakening of the sarcolemma; (2)
inappropriate calcium influx; (3) aberrant
cell signaling (angiogenesis); (4) increased
oxidative stress; and (5) recurrent muscle
ischemia (Markert et al., 2012). The pur-
pose of this manuscript is to discuss each
one of these mechanisms as it relates to
what is known about low load resistance
exercise in combination with BFR.
MECHANICAL WEAKENING
Muscles that lack dystrophin result in
sarcolemmal fragility, making the mus-
cle easily susceptible to damage (Menke
and Jockusch, 1995). Maximal eccentric
contractions are known to result in muscle
damage; however, this is not observed with
submaximal exercise in combination with
BFR (unpublished observations). Despite
this lack of muscle damage, pronounced
changes in muscle mass and strength
occur (Loenneke et al., 2012c). Recent
research suggests that the concentric mus-
cle action is playing the most important
role with respect to changes in muscle
mass and strength (Yasuda et al., 2012).
Therefore, it is conceivable that patients
with DMD could possibly increase muscle
size and strength from completing sub-
maximal concentric only muscle actions
with BFR, which has not been observed
to increase any indices of muscle damage
in healthy subjects (unpublished observa-
tions). However, it is acknowledged that
this response may be different in patients
in DMD, who already have a fragile sar-
colemma.
CALCIUM INFLUX
The maintenance of calcium at an appro-
priate level in skeletal muscle (resting
cytosolic concentration of ∼50 nM) is
important and when calcium is not prop-
erly regulated, muscle degradation can
occur. The mechanism behind this mus-
cle degradation is not completely known,
however, one proposed mechanism is an
increase in calpains. Calpain 3 is tightly
bound to titin and is involved in degra-
dation by disassembling the outer layers
of proteins from the myofibril. Muscles
of mdx mice have increased calpain con-
centration and activity (Spencer et al.,
1995), which is diminished in mdx mice
that overexpress calpastatin (Spencer and
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Mellgren, 2002). Interestingly, it has been
recently hypothesized that calpastatins are
likely increased with the application of
BFR (Loenneke et al., 2012d). The possible
increase in calpastatin with BFR is thought
to occur through signaling of the beta 2
adrenoceptor following binding of nore-
pinephrine. Although theoretically plausi-
ble due to the increase in norepinephrine
following the application of BFR, future
work is needed to determine if the increase
in calpastatin actually occurs in healthy or
DMDmuscle.
ANGIOGENESIS
Angiogenesis in skeletal muscle results
from hypoxia, shear stress, and increases in
growth factors such as vascular endothelial
growth factor (VEGF) (Larkin et al., 2012).
In addition, there is evidence that the fre-
quency of mesenchymal stem cells (MSCs)
correlates with blood vessel density (Da
Silva Meirelles et al., 2009) which sug-
gests that angiogenesis may increase the
availability of MSCs for regenerating tis-
sue in patients with DMD. Recently, low
load resistance exercise in combination
with BFR has been observed to increase
post-exercise expression of mRNA related
to skeletal muscle angiogenesis in healthy
young adults (Larkin et al., 2012). This
provides proof of concept for possible
future work in patients with DMD to
determine if tissue regeneration is possi-
ble following exercise in combination with
BFR. However, it should also be men-
tioned that if the availability of MSCs
is increased with exercise in combination
with BFR, these MSCs would carry the
same genetic mutations as the patients’
somatic cells (Markert et al., 2012).
OXIDATIVE STRESS
Oxidative stress is a biological phe-
nomenon marked by an imbalance
between reactive free radicals and antiox-
idant defenses. When oxidative stress
is severe and/or prolonged, the natural
defense system can be overwhelmed, lead-
ing to subsequent oxidative damage of
lipids, proteins, and DNA. Lipids com-
prise part of the sarcolemma and these
lipids are preferentially attacked by reac-
tive oxygen and nitrogen species (Murphy
and Kehrer, 1989). If this attack is not
corrected by antioxidants, it could lead to
the destruction of the contractile units
of the muscle cell, actin, and myosin.
Although heavy resistance training can
increase oxidative stress, submaximal
exercise with BFR has not been shown
to increase oxidative stress in those who
are healthy (Goldfarb et al., 2008) or in
those with heart disease (Madarame et al.,
2013). Therefore, exercise with BFR may
be able to increase/maintain muscle func-
tion in those with DMD without further
increasing levels of oxidative stress.
RECURRENT MUSCLE ISCHEMIA
There is some mechanistic evidence for
recurrent muscle ischemia in the muscle of
DMD patients. Briefly, studies have shown
that in healthy skeletal muscle, blood flow
during exercise is increased to the work-
ing muscle due to nitric oxide release.
However, this does not occur in DMD
muscle, therefore the reflex sympathetic
vasoconstriction that accompanies con-
traction of DMD muscle is unopposed by
nitric oxide mediated vasodilation result-
ing in ischemic muscle (Markert et al.,
2012). Although the application of BFR
during exercise is acute and brief, it is
possible that this impaired vascular con-
trol in those with DMD could contraindi-
cate them to this mode of exercise. The
only evidence available to suggest BFR in
combination with exercise may be safe
in this population comes from a single
case study from a patient with idiopathic
inflammatory myopathy (Gualano et al.,
2010). It has been hypothesized that idio-
pathic inflammatory myopathies also have
impaired vascular function (Grundtman
and Lundberg, 2009), suggesting that
improvements in muscle function may
occur following acute bouts of BFR exer-
cise in patients with a compromised vas-
cular system. However, the mechanism
of vascular dysfunction for idiopathic
inflammatory myopathy is different than
that for DMD; therefore direct compar-
isons between the two conditions should
be made with caution.
CONCLUSION
In conclusion, we wish to suggest the pos-
sibility that the application of BFR in com-
bination with exercise may be beneficial
for maintaining/increasing muscle func-
tion in patients with DMD. This is based
on the observations that BFR in combi-
nation with submaximal exercise increases
muscle function without increasing mark-
ers of muscle damage or oxidative stress.
Future research is needed to confirm that
these effects largely observed in healthy
subjects, would transfer to patients with
DMD. It may be useful to first design and
test this theory in an animal model to
determine proof of concept.
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